Zobrazeno 1 - 10
of 72
pro vyhledávání: ''
Autor:
Michihide Tokuhira, Keiji Sugimoto, Tomoiku Takaku, Noriyoshi Iriyama, Isao Fujioka, Hiroyuki Fujita, Maho Ishikawa, Tatsuya Kawaguchi, Yuta Kimura, Tomonori Nakazato, Norio Asou, Norio Komatsu, Eriko Sato, Yoshihiro Hatta, Masahiro Kizaki
Publikováno v:
Medical oncology (Northwood, London, England). 35(11)
Background and Aim: Treatment with a tyrosine kinase inhibitor (TKI) is the standard of care for patients with chronic myeloid leukemia (CML). Based on the results of the ENESTnd and DASISION studies, the European LeukemiaNet 2013 guidelines now reco
Autor:
Xian De Liu, Meixiang Sang, B. Shan, Yalei Lv, Yudong Wang, Xiaojie Fan, Jing Han, Xinliang Zhou, Haifeng Zhu, Wei Liu
Publikováno v:
Medical oncology (Northwood, London, England). 32(1)
Gastric cancer is the fourth most common malignancy in the world. Although microRNA-200 (miR-200) family members are thought to play roles in tumorigenesis, their functions in carcinogenesis are tumor specific, and the underlying mechanism of action
Autor:
Jing Yang, Hong Guo, Ying-Ying Zhang, Qin Chen, Xiang-Mei Wen, Jiang Lin, Dong-ming Yao, Ji-chun Ma, Lei Yang, Jun Qian, Jing-Dong Zhou
Publikováno v:
Medical oncology (Northwood, London, England). 32(1)
To investigate the expression of brain and acute leukemia, cytoplasmic (BAALC) and analyze its clinical significance in Chinese de novo acute myeloid leukemia (AML). Real-time quantitative PCR (RQ-PCR) was carried out to detect BAALC transcript level
Autor:
Anders Wikby, Fredrik Jönson, Lars Erik Rutqvist, Jan Lundgren, Nongnit Laytragoon-Lewin, Freddi Lewin, Sture Löfgren
Publikováno v:
Medical oncology (Northwood, London, England). 31(12)
Long-term survival of H&N cancer patients has not improved significantly over the last 30 years. The possibility of using circulating blood cell phenotypes as a prognostic biomarker of H&N cancer patient was investigated in this study. Pre-treatment,
Autor:
Walaa A Elsalakawy, Mohamed A. M. Ali
Publikováno v:
Medical oncology (Northwood, London, England). 31(11)
Imatinib mesylate (IM) has so far been the standard of care for treating chronic myeloid leukemia (CML), but the initial striking efficacy of this drug has been overshadowed by the development of clinical resistance, which may in part be caused by ph
Autor:
Tao Xu, Sumei Wang, Weihong Wei, Donghui Wang, Chunhua Wang, Weihan Hu, Guoyi Zhang, Bojin Su, Huiling Yang, Zheli Huang, Jun Jiang
Publikováno v:
Medical oncology (Northwood, London, England). 31(10)
In this retrospective study, the correlation between pre- and post-treatment plasma Epstein–Barr virus (EBV) DNA and circulating immune subsets as well as the prognostic implications was investigated in nasopharyngeal carcinoma (NPC) patients. Pati
Autor:
Changfu Zhang, Shuangyi Ren, Wenbin Chen, Zhe Chen, Yunfei Zuo, Yanmei Jiang, Ziyi Yang, Dongbing Ding, Xudong Jiang
Publikováno v:
Medical oncology (Northwood, London, England). 31(10)
Dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN), a member of the C-type lectin superfamily, has been reported to bind to various pathogens and several tumor cells and to participate in immunoregulation. It is
Autor:
Yang Jin, Jiao Du, Qi Huang, Xiuxiu Zhang, Feng Wu, Jieli Han, Zhilei Lv, Xin Qian, Caiyun Chen, Jinshuo Fan
Publikováno v:
Medical oncology (Northwood, London, England). 31(9)
Interleukin-17 receptor (IL-17RA) is essential for proinflammatory cytokine IL-17-mediated pathogenesis of various tumors. IL-17RA is upregulated by some proinflammatory cytokines such as IL-21 and IL-15 and downregulated by IL-2, while the effect of
Publikováno v:
Medical oncology (Northwood, London, England). 31(8)
The open-label, prospective, observational study aimed to evaluate whether the addition of maintenance rituximab (MR) improved progression-free survival (PFS) and overall survival (OS), after fludarabine, cyclophosphamide, and rituximab (FCR) for cyt
Publikováno v:
Medical oncology (Northwood, London, England). 31(8)
The study aims to investigate whether the glutathione S transferase P1 (GSTP1) and excision repair cross-complementing group 1 (ERCC1) polymorphism influence the response to treatment with platinum-based chemotherapy in Chinese patients with non-smal